COVID-19 figures decreasing, but still high There were 1,998 new hospital admissions of patients with COVID-19 last week, 7% less than the week before. 343 new patients with COVID-19 were admitted to ICU, a 9% decrease.
Omicron variant confirmed in another 18 people in the Netherlands RIVM is monitoring the spread of the Omicron variant in various ways. For that purpose, the test samples taken from people who tested positive for COVID-19 are subjected to further analysis.
Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP
Healthcare utilisation increases with Long COVID symptoms More than 15,000 people are taking part in the LongCOVID study conducted by RIVM. Participants with existing long-term symptoms after COVID-19 (Long COVID) reported higher healthcare utilisation.
Increase in percentage of positive tests, stabilisation in hospital admissions In the past week, from 21 to 27 April, the reported number of people who tested positive for COVID-19 increased slightly to 55,097 newly reported infections (+2%)*.
One in ten tests positive In the past week, from 14 to 20 April, the reported number of people who tested positive for COVID-19 increased by 5.3%, rising to 53,981 newly reported infections.
Support for ‘corona passport’, downward trend in compliance with visitor limits There seems to be widespread support for introducing a coronavirus passport, also referred to as ‘corona passport’.
Fewer coronavirus infections among people who kept distancing People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.
Coronavirus monitoring in sewage research expanded and extended Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.